Go Pro

BSF Enterprise (BSFA) Competitors

BSF Enterprise logo
GBX 1.18 +0.06 (+4.89%)
As of 12:31 PM Eastern

BSFA vs. IDP, OPTI, N4P, CHLL, and GILD

Should you buy BSF Enterprise stock or one of its competitors? BSF Enterprise's main competitors and comparable companies include InnovaDerma (IDP), OptiBiotix Health (OPTI), N4 Pharma (N4P), Chill Brands Group (CHLL), and Guild Esports (GILD). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "pharmaceuticals" industry.

How does BSF Enterprise compare to InnovaDerma?

BSF Enterprise (LON:BSFA) and InnovaDerma (LON:IDP) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, analyst recommendations, dividends, earnings, profitability, risk and valuation.

InnovaDerma has a net margin of 0.00% compared to BSF Enterprise's net margin of -2,505.69%. InnovaDerma's return on equity of 0.00% beat BSF Enterprise's return on equity.

Company Net Margins Return on Equity Return on Assets
BSF Enterprise-2,505.69% -57.16% -20.65%
InnovaDerma N/A N/A N/A

In the previous week, BSF Enterprise's average media sentiment score of 0.00 equaled InnovaDerma'saverage media sentiment score.

Company Overall Sentiment
BSF Enterprise Neutral
InnovaDerma Neutral

InnovaDerma has higher revenue and earnings than BSF Enterprise. BSF Enterprise is trading at a lower price-to-earnings ratio than InnovaDerma, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BSF Enterprise£51.07K47.28-£2.04M-£1.02N/A
InnovaDerma£9.82M0.00N/A-£7.50N/A

Summary

InnovaDerma beats BSF Enterprise on 4 of the 6 factors compared between the two stocks.

How does BSF Enterprise compare to OptiBiotix Health?

OptiBiotix Health (LON:OPTI) and BSF Enterprise (LON:BSFA) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, valuation, dividends, media sentiment, risk, profitability and institutional ownership.

OptiBiotix Health has a net margin of -332.69% compared to BSF Enterprise's net margin of -2,505.69%. BSF Enterprise's return on equity of -57.16% beat OptiBiotix Health's return on equity.

Company Net Margins Return on Equity Return on Assets
OptiBiotix Health-332.69% -77.85% -13.93%
BSF Enterprise -2,505.69%-57.16%-20.65%

OptiBiotix Health has a beta of 1.82, suggesting that its stock price is 82% more volatile than the broader market. Comparatively, BSF Enterprise has a beta of 3.639, suggesting that its stock price is 264% more volatile than the broader market.

In the previous week, OptiBiotix Health's average media sentiment score of 0.00 equaled BSF Enterprise'saverage media sentiment score.

Company Overall Sentiment
OptiBiotix Health Neutral
BSF Enterprise Neutral

0.4% of OptiBiotix Health shares are held by institutional investors. 26.8% of OptiBiotix Health shares are held by company insiders. Comparatively, 10.9% of BSF Enterprise shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

BSF Enterprise has lower revenue, but higher earnings than OptiBiotix Health. OptiBiotix Health is trading at a lower price-to-earnings ratio than BSF Enterprise, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
OptiBiotix Health£1.29M4.73-£3.09M-£3.84N/A
BSF Enterprise£51.07K47.28-£2.04M-£1.02N/A

Summary

BSF Enterprise beats OptiBiotix Health on 6 of the 11 factors compared between the two stocks.

How does BSF Enterprise compare to N4 Pharma?

BSF Enterprise (LON:BSFA) and N4 Pharma (LON:N4P) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, profitability, institutional ownership, media sentiment, earnings, risk, dividends and analyst recommendations.

BSF Enterprise has a beta of 3.639, suggesting that its stock price is 264% more volatile than the broader market. Comparatively, N4 Pharma has a beta of -0.37, suggesting that its stock price is 137% less volatile than the broader market.

N4 Pharma has lower revenue, but higher earnings than BSF Enterprise. N4 Pharma is trading at a lower price-to-earnings ratio than BSF Enterprise, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BSF Enterprise£51.07K47.28-£2.04M-£1.02N/A
N4 Pharma£7.07K800.95-£1.63M-£0.24N/A

0.2% of N4 Pharma shares are held by institutional investors. 10.9% of BSF Enterprise shares are held by company insiders. Comparatively, 22.0% of N4 Pharma shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

BSF Enterprise has a net margin of -2,505.69% compared to N4 Pharma's net margin of -14,542.71%. BSF Enterprise's return on equity of -57.16% beat N4 Pharma's return on equity.

Company Net Margins Return on Equity Return on Assets
BSF Enterprise-2,505.69% -57.16% -20.65%
N4 Pharma -14,542.71%-119.30%-56.00%

In the previous week, BSF Enterprise's average media sentiment score of 0.00 equaled N4 Pharma'saverage media sentiment score.

Company Overall Sentiment
BSF Enterprise Neutral
N4 Pharma Neutral

Summary

BSF Enterprise beats N4 Pharma on 6 of the 11 factors compared between the two stocks.

How does BSF Enterprise compare to Chill Brands Group?

Chill Brands Group (LON:CHLL) and BSF Enterprise (LON:BSFA) are both small-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, dividends, analyst recommendations, media sentiment, profitability, risk, institutional ownership and valuation.

Chill Brands Group has a beta of 0.99, indicating that its stock price is 1% less volatile than the broader market. Comparatively, BSF Enterprise has a beta of 3.639, indicating that its stock price is 264% more volatile than the broader market.

In the previous week, Chill Brands Group had 1 more articles in the media than BSF Enterprise. MarketBeat recorded 1 mentions for Chill Brands Group and 0 mentions for BSF Enterprise. BSF Enterprise's average media sentiment score of 0.00 beat Chill Brands Group's score of -0.71 indicating that BSF Enterprise is being referred to more favorably in the news media.

Company Overall Sentiment
Chill Brands Group Negative
BSF Enterprise Neutral

BSF Enterprise has lower revenue, but higher earnings than Chill Brands Group. BSF Enterprise is trading at a lower price-to-earnings ratio than Chill Brands Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Chill Brands Group£305.70K3.08-£3.64M-£6.50N/A
BSF Enterprise£51.07K47.28-£2.04M-£1.02N/A

Chill Brands Group has a net margin of 0.00% compared to BSF Enterprise's net margin of -2,505.69%. BSF Enterprise's return on equity of -57.16% beat Chill Brands Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Chill Brands GroupN/A -2,802.21% -44.64%
BSF Enterprise -2,505.69%-57.16%-20.65%

1.5% of Chill Brands Group shares are owned by institutional investors. 10.3% of Chill Brands Group shares are owned by company insiders. Comparatively, 10.9% of BSF Enterprise shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

BSF Enterprise beats Chill Brands Group on 8 of the 13 factors compared between the two stocks.

How does BSF Enterprise compare to Guild Esports?

BSF Enterprise (LON:BSFA) and Guild Esports (LON:GILD) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, profitability, valuation, dividends, earnings, analyst recommendations, institutional ownership and risk.

BSF Enterprise has a beta of 3.639, meaning that its stock price is 264% more volatile than the broader market. Comparatively, Guild Esports has a beta of 1.02, meaning that its stock price is 2% more volatile than the broader market.

BSF Enterprise has higher earnings, but lower revenue than Guild Esports. BSF Enterprise is trading at a lower price-to-earnings ratio than Guild Esports, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BSF Enterprise£51.07K47.28-£2.04M-£1.02N/A
Guild Esports£3.92M0.00-£4.01M-£0.01N/A

Guild Esports has a net margin of -102.32% compared to BSF Enterprise's net margin of -2,505.69%. BSF Enterprise's return on equity of -57.16% beat Guild Esports' return on equity.

Company Net Margins Return on Equity Return on Assets
BSF Enterprise-2,505.69% -57.16% -20.65%
Guild Esports -102.32%-270.33%-37.72%

3.3% of Guild Esports shares are held by institutional investors. 10.9% of BSF Enterprise shares are held by insiders. Comparatively, 42.4% of Guild Esports shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, BSF Enterprise's average media sentiment score of 0.00 equaled Guild Esports'average media sentiment score.

Company Overall Sentiment
BSF Enterprise Neutral
Guild Esports Neutral

Summary

BSF Enterprise and Guild Esports tied by winning 5 of the 10 factors compared between the two stocks.

Get BSF Enterprise News Delivered to You Automatically

Sign up to receive the latest news and ratings for BSFA and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BSFA vs. The Competition

MetricBSF EnterprisePharmaceuticals IndustryHealthcare SectorLON Exchange
Market Cap£2.40M£12.22B£7.11B£2.80B
Dividend YieldN/A2.63%2.53%6.18%
P/E Ratio-1.16797.14274.42366.17
Price / Sales47.08751.87600.7289,425.29
Price / Cash10.3081.7977.3827.89
Price / Book0.3810.4710.926.83
Net Income-£2.04M£2.83B£3.50B£5.89B
7 Day Performance26.34%-1.64%-2.07%-0.75%
1 Month Performance15.12%-5.80%-6.32%16.84%
1 Year Performance-60.67%-3.84%8.92%16.40%

BSF Enterprise Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BSFA
BSF Enterprise
N/AGBX 1.18
+4.9%
N/A-62.5%£2.40M£51.07KN/A12
IDP
InnovaDerma
N/AN/AN/AN/A£8.14M£9.82MN/A8,720
OPTI
OptiBiotix Health
N/AGBX 5.95
flat
N/A-50.4%£6.15M£1.29MN/A1
N4P
N4 Pharma
N/AGBX 0.68
flat
N/A+7.4%£5.66M£7.07KN/A5
CHLL
Chill Brands Group
N/AGBX 1.90
-0.2%
N/A+11.6%£993K£305.70KN/A7

Related Companies and Tools


This page (LON:BSFA) was last updated on 10/2/2026 by MarketBeat.com Staff.
From Our Partners